CN114794346A - Formula of composite solid beverage - Google Patents
Formula of composite solid beverage Download PDFInfo
- Publication number
- CN114794346A CN114794346A CN202210439576.2A CN202210439576A CN114794346A CN 114794346 A CN114794346 A CN 114794346A CN 202210439576 A CN202210439576 A CN 202210439576A CN 114794346 A CN114794346 A CN 114794346A
- Authority
- CN
- China
- Prior art keywords
- powder
- formula
- mixing
- stirring
- mixed
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 235000013361 beverage Nutrition 0.000 title claims abstract description 48
- 239000007787 solid Substances 0.000 title claims abstract description 42
- 239000002131 composite material Substances 0.000 title claims abstract description 11
- 239000000843 powder Substances 0.000 claims abstract description 116
- 238000003756 stirring Methods 0.000 claims abstract description 68
- 239000011812 mixed powder Substances 0.000 claims abstract description 65
- KRKNYBCHXYNGOX-UHFFFAOYSA-N citric acid Natural products OC(=O)CC(O)(C(O)=O)CC(O)=O KRKNYBCHXYNGOX-UHFFFAOYSA-N 0.000 claims abstract description 42
- 239000001509 sodium citrate Substances 0.000 claims abstract description 29
- NLJMYIDDQXHKNR-UHFFFAOYSA-K sodium citrate Chemical compound O.O.[Na+].[Na+].[Na+].[O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O NLJMYIDDQXHKNR-UHFFFAOYSA-K 0.000 claims abstract description 29
- JYJIGFIDKWBXDU-MNNPPOADSA-N inulin Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)OC[C@]1(OC[C@]2(OC[C@]3(OC[C@]4(OC[C@]5(OC[C@]6(OC[C@]7(OC[C@]8(OC[C@]9(OC[C@]%10(OC[C@]%11(OC[C@]%12(OC[C@]%13(OC[C@]%14(OC[C@]%15(OC[C@]%16(OC[C@]%17(OC[C@]%18(OC[C@]%19(OC[C@]%20(OC[C@]%21(OC[C@]%22(OC[C@]%23(OC[C@]%24(OC[C@]%25(OC[C@]%26(OC[C@]%27(OC[C@]%28(OC[C@]%29(OC[C@]%30(OC[C@]%31(OC[C@]%32(OC[C@]%33(OC[C@]%34(OC[C@]%35(OC[C@]%36(O[C@@H]%37[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O%37)O)[C@H]([C@H](O)[C@@H](CO)O%36)O)[C@H]([C@H](O)[C@@H](CO)O%35)O)[C@H]([C@H](O)[C@@H](CO)O%34)O)[C@H]([C@H](O)[C@@H](CO)O%33)O)[C@H]([C@H](O)[C@@H](CO)O%32)O)[C@H]([C@H](O)[C@@H](CO)O%31)O)[C@H]([C@H](O)[C@@H](CO)O%30)O)[C@H]([C@H](O)[C@@H](CO)O%29)O)[C@H]([C@H](O)[C@@H](CO)O%28)O)[C@H]([C@H](O)[C@@H](CO)O%27)O)[C@H]([C@H](O)[C@@H](CO)O%26)O)[C@H]([C@H](O)[C@@H](CO)O%25)O)[C@H]([C@H](O)[C@@H](CO)O%24)O)[C@H]([C@H](O)[C@@H](CO)O%23)O)[C@H]([C@H](O)[C@@H](CO)O%22)O)[C@H]([C@H](O)[C@@H](CO)O%21)O)[C@H]([C@H](O)[C@@H](CO)O%20)O)[C@H]([C@H](O)[C@@H](CO)O%19)O)[C@H]([C@H](O)[C@@H](CO)O%18)O)[C@H]([C@H](O)[C@@H](CO)O%17)O)[C@H]([C@H](O)[C@@H](CO)O%16)O)[C@H]([C@H](O)[C@@H](CO)O%15)O)[C@H]([C@H](O)[C@@H](CO)O%14)O)[C@H]([C@H](O)[C@@H](CO)O%13)O)[C@H]([C@H](O)[C@@H](CO)O%12)O)[C@H]([C@H](O)[C@@H](CO)O%11)O)[C@H]([C@H](O)[C@@H](CO)O%10)O)[C@H]([C@H](O)[C@@H](CO)O9)O)[C@H]([C@H](O)[C@@H](CO)O8)O)[C@H]([C@H](O)[C@@H](CO)O7)O)[C@H]([C@H](O)[C@@H](CO)O6)O)[C@H]([C@H](O)[C@@H](CO)O5)O)[C@H]([C@H](O)[C@@H](CO)O4)O)[C@H]([C@H](O)[C@@H](CO)O3)O)[C@H]([C@H](O)[C@@H](CO)O2)O)[C@@H](O)[C@H](O)[C@@H](CO)O1 JYJIGFIDKWBXDU-MNNPPOADSA-N 0.000 claims abstract description 17
- 229930189775 mogroside Natural products 0.000 claims abstract description 16
- 238000005303 weighing Methods 0.000 claims abstract description 10
- 229920001353 Dextrin Polymers 0.000 claims description 14
- 239000004375 Dextrin Substances 0.000 claims description 14
- 239000004386 Erythritol Substances 0.000 claims description 14
- UNXHWFMMPAWVPI-UHFFFAOYSA-N Erythritol Natural products OCC(O)C(O)CO UNXHWFMMPAWVPI-UHFFFAOYSA-N 0.000 claims description 14
- 235000019425 dextrin Nutrition 0.000 claims description 14
- UNXHWFMMPAWVPI-ZXZARUISSA-N erythritol Chemical compound OC[C@H](O)[C@H](O)CO UNXHWFMMPAWVPI-ZXZARUISSA-N 0.000 claims description 14
- 235000019414 erythritol Nutrition 0.000 claims description 14
- 229940009714 erythritol Drugs 0.000 claims description 14
- WBZFUFAFFUEMEI-UHFFFAOYSA-M Acesulfame k Chemical compound [K+].CC1=CC(=O)[N-]S(=O)(=O)O1 WBZFUFAFFUEMEI-UHFFFAOYSA-M 0.000 claims description 13
- 229960004998 acesulfame potassium Drugs 0.000 claims description 13
- 235000010358 acesulfame potassium Nutrition 0.000 claims description 13
- 239000000619 acesulfame-K Substances 0.000 claims description 13
- 150000001875 compounds Chemical class 0.000 claims description 8
- 230000009286 beneficial effect Effects 0.000 abstract description 8
- 239000008280 blood Substances 0.000 abstract description 8
- 210000004369 blood Anatomy 0.000 abstract description 8
- 230000000694 effects Effects 0.000 abstract description 7
- 235000003599 food sweetener Nutrition 0.000 abstract description 6
- 239000003765 sweetening agent Substances 0.000 abstract description 6
- 206010010774 Constipation Diseases 0.000 abstract description 4
- 206010012601 diabetes mellitus Diseases 0.000 abstract description 4
- 230000036541 health Effects 0.000 abstract description 4
- 210000000936 intestine Anatomy 0.000 abstract description 4
- 235000000346 sugar Nutrition 0.000 abstract description 3
- 229930091371 Fructose Natural products 0.000 abstract description 2
- RFSUNEUAIZKAJO-ARQDHWQXSA-N Fructose Chemical compound OC[C@H]1O[C@](O)(CO)[C@@H](O)[C@@H]1O RFSUNEUAIZKAJO-ARQDHWQXSA-N 0.000 abstract description 2
- 239000005715 Fructose Substances 0.000 abstract description 2
- 229920001202 Inulin Polymers 0.000 abstract description 2
- 208000008589 Obesity Diseases 0.000 abstract description 2
- 229930006000 Sucrose Natural products 0.000 abstract description 2
- CZMRCDWAGMRECN-UGDNZRGBSA-N Sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 abstract description 2
- 230000036772 blood pressure Effects 0.000 abstract description 2
- 239000000284 extract Substances 0.000 abstract description 2
- 230000007413 intestinal health Effects 0.000 abstract description 2
- 229940029339 inulin Drugs 0.000 abstract description 2
- 210000004072 lung Anatomy 0.000 abstract description 2
- 235000020824 obesity Nutrition 0.000 abstract description 2
- 235000013406 prebiotics Nutrition 0.000 abstract description 2
- 230000002040 relaxant effect Effects 0.000 abstract description 2
- 229960004793 sucrose Drugs 0.000 abstract description 2
- 230000001502 supplementing effect Effects 0.000 abstract description 2
- 239000011782 vitamin Substances 0.000 abstract description 2
- 229940088594 vitamin Drugs 0.000 abstract description 2
- 229930003231 vitamin Natural products 0.000 abstract description 2
- 235000013343 vitamin Nutrition 0.000 abstract description 2
- UIIMBOGNXHQVGW-UHFFFAOYSA-M Sodium bicarbonate Chemical compound [Na+].OC([O-])=O UIIMBOGNXHQVGW-UHFFFAOYSA-M 0.000 description 12
- 239000000203 mixture Substances 0.000 description 9
- ZLMJMSJWJFRBEC-UHFFFAOYSA-N Potassium Chemical compound [K] ZLMJMSJWJFRBEC-UHFFFAOYSA-N 0.000 description 8
- 229960003975 potassium Drugs 0.000 description 8
- 229910052700 potassium Inorganic materials 0.000 description 8
- 239000011591 potassium Substances 0.000 description 8
- 239000000243 solution Substances 0.000 description 8
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 8
- 239000004615 ingredient Substances 0.000 description 7
- 238000009472 formulation Methods 0.000 description 6
- 229910000030 sodium bicarbonate Inorganic materials 0.000 description 6
- 235000017557 sodium bicarbonate Nutrition 0.000 description 6
- 241000167854 Bourreria succulenta Species 0.000 description 5
- 235000019693 cherries Nutrition 0.000 description 5
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 4
- 239000002245 particle Substances 0.000 description 4
- 239000001508 potassium citrate Substances 0.000 description 4
- 229960002635 potassium citrate Drugs 0.000 description 4
- QEEAPRPFLLJWCF-UHFFFAOYSA-K potassium citrate (anhydrous) Chemical compound [K+].[K+].[K+].[O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O QEEAPRPFLLJWCF-UHFFFAOYSA-K 0.000 description 4
- 235000011082 potassium citrates Nutrition 0.000 description 4
- 239000000047 product Substances 0.000 description 4
- UEDUENGHJMELGK-HYDKPPNVSA-N Stevioside Chemical compound O([C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1O[C@]12C(=C)C[C@@]3(C1)CC[C@@H]1[C@@](C)(CCC[C@]1([C@@H]3CC2)C)C(=O)O[C@H]1[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O1)O)[C@@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O UEDUENGHJMELGK-HYDKPPNVSA-N 0.000 description 3
- 201000010099 disease Diseases 0.000 description 3
- 239000000796 flavoring agent Substances 0.000 description 3
- 229940013618 stevioside Drugs 0.000 description 3
- OHHNJQXIOPOJSC-UHFFFAOYSA-N stevioside Natural products CC1(CCCC2(C)C3(C)CCC4(CC3(CCC12C)CC4=C)OC5OC(CO)C(O)C(O)C5OC6OC(CO)C(O)C(O)C6O)C(=O)OC7OC(CO)C(O)C(O)C7O OHHNJQXIOPOJSC-UHFFFAOYSA-N 0.000 description 3
- 235000019202 steviosides Nutrition 0.000 description 3
- 208000001889 Acid-Base Imbalance Diseases 0.000 description 2
- 208000010444 Acidosis Diseases 0.000 description 2
- 206010013911 Dysgeusia Diseases 0.000 description 2
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 description 2
- 206010027417 Metabolic acidosis Diseases 0.000 description 2
- 208000000418 Premature Cardiac Complexes Diseases 0.000 description 2
- 208000007107 Stomach Ulcer Diseases 0.000 description 2
- 206010003119 arrhythmia Diseases 0.000 description 2
- 230000006793 arrhythmia Effects 0.000 description 2
- 239000013078 crystal Substances 0.000 description 2
- 230000007547 defect Effects 0.000 description 2
- 235000013601 eggs Nutrition 0.000 description 2
- 235000013355 food flavoring agent Nutrition 0.000 description 2
- 201000005917 gastric ulcer Diseases 0.000 description 2
- 208000019622 heart disease Diseases 0.000 description 2
- 235000021539 instant coffee Nutrition 0.000 description 2
- 239000007788 liquid Substances 0.000 description 2
- 230000008376 long-term health Effects 0.000 description 2
- 208000020470 nervous system symptom Diseases 0.000 description 2
- YPSNMKHPDJVGEX-UHFFFAOYSA-L potassium;sodium;3-carboxy-3-hydroxypentanedioate Chemical compound [Na+].[K+].OC(=O)CC(O)(C([O-])=O)CC([O-])=O YPSNMKHPDJVGEX-UHFFFAOYSA-L 0.000 description 2
- 235000015598 salt intake Nutrition 0.000 description 2
- 229910052708 sodium Inorganic materials 0.000 description 2
- 239000011734 sodium Substances 0.000 description 2
- 229910001415 sodium ion Inorganic materials 0.000 description 2
- 159000000000 sodium salts Chemical class 0.000 description 2
- 239000012265 solid product Substances 0.000 description 2
- 230000000638 stimulation Effects 0.000 description 2
- 210000002784 stomach Anatomy 0.000 description 2
- 239000013589 supplement Substances 0.000 description 2
- SPRBJFWIUVWXBT-UHFFFAOYSA-K tripotassium 2-hydroxypropane-1,2,3-tricarboxylate 2-hydroxypropane-1,2,3-tricarboxylic acid Chemical compound [K+].[K+].[K+].OC(=O)CC(O)(C(O)=O)CC(O)=O.[O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O SPRBJFWIUVWXBT-UHFFFAOYSA-K 0.000 description 2
- XPFJYKARVSSRHE-UHFFFAOYSA-K trisodium;2-hydroxypropane-1,2,3-tricarboxylate;2-hydroxypropane-1,2,3-tricarboxylic acid Chemical compound [Na+].[Na+].[Na+].OC(=O)CC(O)(C(O)=O)CC(O)=O.[O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O XPFJYKARVSSRHE-UHFFFAOYSA-K 0.000 description 2
- 208000023275 Autoimmune disease Diseases 0.000 description 1
- 235000007516 Chrysanthemum Nutrition 0.000 description 1
- 244000189548 Chrysanthemum x morifolium Species 0.000 description 1
- 102000004190 Enzymes Human genes 0.000 description 1
- 108090000790 Enzymes Proteins 0.000 description 1
- 235000010627 Phaseolus vulgaris Nutrition 0.000 description 1
- 244000046052 Phaseolus vulgaris Species 0.000 description 1
- 235000009508 confectionery Nutrition 0.000 description 1
- 235000013365 dairy product Nutrition 0.000 description 1
- 208000035475 disorder Diseases 0.000 description 1
- 230000035622 drinking Effects 0.000 description 1
- 235000013399 edible fruits Nutrition 0.000 description 1
- 235000018927 edible plant Nutrition 0.000 description 1
- 235000019634 flavors Nutrition 0.000 description 1
- 235000013373 food additive Nutrition 0.000 description 1
- 239000002778 food additive Substances 0.000 description 1
- 235000015203 fruit juice Nutrition 0.000 description 1
- 230000002068 genetic effect Effects 0.000 description 1
- 239000007924 injection Substances 0.000 description 1
- 238000002347 injection Methods 0.000 description 1
- 208000017169 kidney disease Diseases 0.000 description 1
- 235000020162 malted milk drink Nutrition 0.000 description 1
- 239000000463 material Substances 0.000 description 1
- 238000000034 method Methods 0.000 description 1
- 244000005700 microbiome Species 0.000 description 1
- 235000013336 milk Nutrition 0.000 description 1
- 239000008267 milk Substances 0.000 description 1
- 210000004080 milk Anatomy 0.000 description 1
- 229920001542 oligosaccharide Polymers 0.000 description 1
- 150000002482 oligosaccharides Chemical class 0.000 description 1
- 239000000419 plant extract Substances 0.000 description 1
- 238000002360 preparation method Methods 0.000 description 1
- 102000004169 proteins and genes Human genes 0.000 description 1
- 108090000623 proteins and genes Proteins 0.000 description 1
- 239000002994 raw material Substances 0.000 description 1
- 201000010384 renal tubular acidosis Diseases 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- 230000010245 tubular reabsorption Effects 0.000 description 1
- 210000002700 urine Anatomy 0.000 description 1
Images
Classifications
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L2/00—Non-alcoholic beverages; Dry compositions or concentrates therefor; Their preparation
- A23L2/385—Concentrates of non-alcoholic beverages
- A23L2/39—Dry compositions
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L2/00—Non-alcoholic beverages; Dry compositions or concentrates therefor; Their preparation
- A23L2/52—Adding ingredients
- A23L2/56—Flavouring or bittering agents
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L2/00—Non-alcoholic beverages; Dry compositions or concentrates therefor; Their preparation
- A23L2/52—Adding ingredients
- A23L2/60—Sweeteners
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/105—Plant extracts, their artificial duplicates or their derivatives
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/125—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives containing carbohydrate syrups; containing sugars; containing sugar alcohols; containing starch hydrolysates
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/20—Reducing nutritive value; Dietetic products with reduced nutritive value
- A23L33/21—Addition of substantially indigestible substances, e.g. dietary fibres
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
Landscapes
- Life Sciences & Earth Sciences (AREA)
- Health & Medical Sciences (AREA)
- Nutrition Science (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Food Science & Technology (AREA)
- Polymers & Plastics (AREA)
- Mycology (AREA)
- Botany (AREA)
- Molecular Biology (AREA)
- Non-Alcoholic Beverages (AREA)
Abstract
The invention discloses a formula of a composite solid beverage, relating to the technical field of solid beverages and comprising the following steps: weighing 2 g of sodium citrate powder and citric acid powder in total, and stirring and mixing; adding a certain amount of inulin powder into the stirred and mixed powder, and stirring and mixing; inulin is added in the formula, is a prebiotic, is beneficial to intestinal health, is beneficial to more people, and solves discomfort such as constipation; the formula is particularly added with fresh orange powder which is a natural orange extract and is beneficial to health by supplementing vitamins and the like required by a human body; the sweetening agent added in the formula is suitable for sub-healthy people or diabetes patients, and is safe and relieved for eating; the sweetening agent in the formula is selected from mogroside, is selected for specific people, has zero heat, has the effects of clearing heat, moistening lung, moistening intestines and relaxing bowels, and is suitable for patients with obesity, constipation or diabetes; the formula does not contain high-calorie sweetening agents such as fructose, cane sugar and the like, does not influence blood pressure, blood fat, blood sugar and the like, and is safe and guaranteed.
Description
Technical Field
The invention relates to the technical field of solid beverages, in particular to a formula of a composite solid beverage.
Background
The solid beverage is a solid product which is prepared by taking sugar, milk and dairy products, eggs or egg products, fruit juice or edible plant extracts and the like as main raw materials and adding a proper amount of auxiliary materials or food additives, wherein the water content of each 100 g of the finished product is not higher than 5 g, and the solid product is in a powder shape, a granular shape or a block shape, such as bean crystal powder, malted milk powder, instant coffee, chrysanthemum crystal and the like, and 3 types of protein type solid beverages, common type solid beverages and baking type solid beverages (instant coffee) are separated. The solid beverage has a water content of 5% or less, and can be taken after dissolving in water. Solid beverages are made from liquid beverages by removing moisture for the purpose of: firstly, the dried beverage is prevented from being deteriorated or putrefied due to enzyme or microorganism of the dried beverage so as to be beneficial to storage; and secondly, the storage and the transportation are convenient. Compared with liquid beverage, the solid beverage has the following characteristics: the weight is obviously reduced, the volume is obviously reduced, and the carrying is convenient; the flavor is good, the instant property is good, the application range is wide, and the drinking is convenient; the sanitation is easy to maintain; the package is simple and easy, and the transportation is convenient.
Metabolic acidosis is a disease frequently encountered in clinic, is an acid-base imbalance caused by renal tubular reabsorption disorder, is called renal tubular acidosis, has wide etiology, and comprises various renal diseases, autoimmune diseases, genetic factors and the like, and the current common treatment scheme is to alkalize urine by oral sodium bicarbonate (sodium bicarbonate tablets) or deliver water (sodium bicarbonate injection or citric acid preparation), wherein citric acid is called citric acid, and is two names of substances. The effect of oral sodium bicarbonate is not good, and the prior technical scheme has the following problems:
1. the sodium citrate beverage (solution) has the net sodium citrate content of 10 percent, no other components are added, the taste is over-salty, the sense is not good, the carrying is inconvenient, the customer acceptance is not high, and the beverage contains too high sodium ions, so that the long-term health influence caused by excessive sodium salt intake can be caused.
2. The potassium sodium hydrogen citrate particles (solid) contain potassium, and the formula product is not suitable for people who do not need to supplement potassium normally and people who have high blood potassium, and is easy to increase blood potassium, so that arrhythmia, premature beat and even serious heart diseases and nervous system symptoms are caused.
3. The potassium citrate beverage (solution) contains 10% of potassium citrate net content and no other components, and is suitable for the safety risks of limited crowds, side effects and the like in the same scheme 2.
4. The scheme of the compound citric acid solution (sodium citrate-citric acid mixture) or (potassium citrate-citric acid total) is mentioned in required documents and is confirmed. The defects are water aqua, which is not easy to carry by customers, and bad taste which affects the compliance of users.
5. The sodium bicarbonate tablet has general effect and dependency on dosage, and additionally has stimulation to the stomach and intestine, aggravates the illness condition of patients with gastric ulcer, and the like;
therefore, the formulation of the compound solid beverage is provided to solve the problems.
Disclosure of Invention
The invention aims to solve the problems in the prior art that:
1. the sodium citrate beverage (solution) has the net sodium citrate content of 10 percent, no other components are added, the taste is over-salty, the sense is not good, the carrying is inconvenient, the customer acceptance is not high, and the beverage contains too high sodium ions, so that the long-term health influence caused by excessive sodium salt intake can be caused.
2. The potassium sodium hydrogen citrate particles (solid) contain potassium, and the formula product is not suitable for people who do not need to supplement potassium normally and people who have high blood potassium, and is easy to increase blood potassium, so that arrhythmia, premature beat and even serious heart diseases and nervous system symptoms are caused.
3. The potassium citrate beverage (solution) contains 10% of potassium citrate net content and no other components, and is suitable for the safety risks of limited crowds, side effects and the like in the same scheme 2.
4. The scheme of the compound citric acid solution (sodium citrate-citric acid mixture) or (potassium citrate-citric acid total) is mentioned in required documents and is confirmed. The defects are water aqua, which is not easy to carry by customers, and bad taste which affects the compliance of users.
5. The sodium bicarbonate tablet has the advantages of common effect, dependence on dosage, stimulation to stomach and intestine, aggravation of the disease of patients with gastric ulcer and the like, and provides a formula of a compound solid beverage.
In order to achieve the purpose, the invention adopts the following technical scheme:
the formula of the compound solid beverage comprises the following steps:
weighing 2 g of sodium citrate powder and citric acid powder in total, and stirring and mixing;
adding a certain amount of inulin powder into the stirred and mixed powder, and stirring and mixing;
adding a certain amount of fresh orange powder into the mixed powder, and stirring and mixing;
adding a certain amount of dextrin powder into the mixed powder, stirring and mixing;
adding a certain amount of mogroside powder into the mixed powder, and stirring and mixing;
adding a certain amount of erythritol powder into the mixed powder, and stirring and mixing;
adding a certain amount of acesulfame potassium powder into the mixed powder, and stirring and mixing to obtain solid beverage powder with the total mass of 5 g.
Preferably, 2 g of sodium citrate powder and 0.8-1.4 g of citric acid powder are weighed and mixed with stirring, wherein the mass of the sodium citrate powder is 0.6-1.2 g, and the mass of the citric acid powder is 0.8-1.4 g.
Preferably, a certain amount of inulin powder is added into the powder after stirring and mixing, and the powder is stirred and mixed, wherein the mass of the inulin powder is 1.2-2 g.
Preferably, a certain amount of fresh orange powder is added into the mixed powder to be stirred and mixed, and the mass of the fresh orange powder is 0.25-1.05 g.
Preferably, a certain amount of dextrin powder is added into the mixed powder to be stirred and mixed, and the mass of the dextrin powder is 0.3-0.8 g.
Preferably, a certain amount of mogroside powder is added into the mixed powder to be stirred and mixed, and the mass of the mogroside powder is 0.05-0.15 g.
Preferably, a certain amount of erythritol powder is added into the mixed powder for stirring and mixing, and the mass of the erythritol powder is 0.05-0.1 g.
Preferably, a certain amount of acesulfame potassium powder is added into the mixed powder to be stirred and mixed, so that solid beverage powder with the total mass of 5 g is obtained, and the mass of the acesulfame potassium powder is 0.01-0.03 g.
Compared with the prior art, the invention has the beneficial effects that:
1. inulin is added in the formula, is prebiotics, is beneficial to intestinal health, benefits more corresponding people and solves discomfort such as constipation; the formula is particularly added with fresh orange powder which is a natural orange extract and is beneficial to health by supplementing vitamins and the like required by a human body; the sweetening agent (flavoring agent) added in the formula is suitable for sub-health people or diabetes patients, and is safe and relieved for eating; the sweetening agent in the formula is selected from mogroside, is selected for specific people, has zero heat, has the effects of clearing heat, moistening lung, moistening intestines and relaxing bowels, and is suitable for patients with obesity, constipation or diabetes; the formula does not contain high-calorie sweetening agents such as fructose, cane sugar and the like, does not influence blood pressure, blood fat, blood sugar and the like, and is safe and guaranteed.
2. The produced solid beverage is convenient to carry and use, and can be taken with warm water or hot water; the shelf life is long, the solid particles are storage-resistant, the shelf life of the formula is 24 months, the storage condition requirement is simple, and the solid particles can be stored at normal temperature; the taste is better, the mixture ratio of citric acid and sodium citrate is proper, and a plurality of flavoring agents are added in a trace amount, so that the taste is sour, sweet and delicious, and the compliance is good; the dosage of the sodium contained in the formula is moderate, and the intake of the daily average sodium content cannot exceed the standard in normal use; the formula is helpful for solving the problem of acid-base imbalance of metabolic acidosis patients, and can help the patients to recover health by a more economical and simple method, reduce health damage caused by diseases, and is beneficial to the patients, families or society.
Drawings
Fig. 1 is a schematic overall flow chart of a formula of a composite solid beverage provided by the invention.
Detailed Description
The technical solutions in the embodiments of the present invention will be clearly and completely described below with reference to the drawings in the embodiments of the present invention, and it is obvious that the described embodiments are only a part of the embodiments of the present invention, and not all of the embodiments.
Referring to fig. 1, a formula of a composite solid beverage comprises the following steps:
s1: weighing 2 g of sodium citrate powder and citric acid powder in total, stirring and mixing, wherein the mass of the sodium citrate powder is 0.6-1.2 g, and the mass of the citric acid powder is 0.8-1.4 g;
s2: adding a certain amount of inulin powder into the stirred and mixed powder, and stirring and mixing, wherein the mass of the inulin powder is 1.2-2 g;
s3: adding a certain amount of fresh orange powder into the mixed powder, stirring and mixing, wherein the mass of the fresh orange powder is 0.25-1.05 g, and the fresh orange powder can be replaced by cherry powder or other fruit powder;
s4: adding a certain amount of dextrin powder into the mixed powder, stirring and mixing, wherein the mass of the dextrin powder is 0.3-0.8 g;
s5: adding a certain amount of mogroside powder into the mixed powder, and stirring and mixing, wherein the mass of the mogroside powder is 0.05-0.15 g;
s6: adding a certain amount of erythritol powder into the mixed powder, stirring and mixing, wherein the mass of the erythritol powder is 0.05-0.1 g;
s7: adding a certain amount of acesulfame potassium powder into the mixed powder, stirring and mixing to obtain solid beverage powder with the total mass of 5 g, wherein the mass of the acesulfame potassium powder is 0.01-0.03 g, and the acesulfame potassium can be replaced by stevioside, oligosaccharide and the like.
The formula table is shown in table 1:
table 1 ingredient formulation table
Example 1:
s1: weighing 2 g of sodium citrate powder and 1.4 g of citric acid powder, and stirring and mixing, wherein the mass of the sodium citrate powder is 0.6 g, and the mass of the citric acid powder is 1.4 g;
s2: adding 1.2 g of inulin powder into the stirred and mixed powder, and stirring and mixing;
s3: adding 1.05 g of fresh orange powder into the mixed powder, and stirring and mixing;
s4: adding 0.5 g of dextrin powder into the mixed powder, stirring and mixing;
s5: adding 0.12 g of mogroside powder into the mixed powder, and stirring and mixing;
s6: adding 0.1 g of erythritol powder into the mixed powder, and stirring and mixing;
s7: 0.03 g of acesulfame potassium powder was added to the mixed powder, followed by mixing with stirring to obtain a solid beverage powder having a total mass of 5 g.
The formula table is shown in table 2:
table 2 ingredient formula table
Example 2:
s1: weighing 2 g of sodium citrate powder and 0.8 g of citric acid powder, and stirring and mixing the sodium citrate powder and the citric acid powder, wherein the mass of the sodium citrate powder is 1.2 g, and the mass of the citric acid powder is 0.8 g;
s2: adding 2 g of inulin powder into the stirred and mixed powder, and stirring and mixing;
s3: adding 0.25 g of fresh orange powder into the mixed powder, and stirring and mixing;
s4: adding 0.64 g of dextrin powder into the mixed powder, and stirring and mixing;
s5: adding 0.05 g of mogroside powder into the mixed powder, and stirring and mixing;
s6: adding 0.05 g of erythritol powder into the mixed powder, and stirring and mixing;
s7: 0.01 g of acesulfame potassium powder was added to the mixed powder, followed by mixing with stirring to obtain a solid beverage powder having a total mass of 5 g.
The formula table is shown in table 3:
table 3 ingredient formulation table
Example 3:
s1: weighing 2 g of sodium citrate powder and 0.8 g of citric acid powder, and stirring and mixing the sodium citrate powder and the citric acid powder, wherein the mass of the sodium citrate powder is 1.2 g, and the mass of the citric acid powder is 0.8 g;
s2: adding 2 g of inulin powder into the stirred and mixed powder, and stirring and mixing;
s3: adding 0.25 g of cherry powder into the mixed powder, and stirring and mixing;
s4: adding 0.64 g of dextrin powder into the mixed powder, stirring and mixing;
s5: adding 0.05 g of mogroside powder into the mixed powder, and stirring and mixing;
s6: adding 0.05 g of erythritol powder into the mixed powder, and stirring and mixing;
s7: 0.01 g of acesulfame potassium powder was added to the mixed powder, followed by mixing with stirring to obtain a solid beverage powder having a total mass of 5 g.
The formula table is shown in table 4:
table 4 ingredient formulation table
Example 4:
s1: weighing 2 g of sodium citrate powder and 1.4 g of citric acid powder, and stirring and mixing, wherein the mass of the sodium citrate powder is 0.6 g, and the mass of the citric acid powder is 1.4 g;
s2: adding 1.2 g of inulin powder into the stirred and mixed powder, and stirring and mixing;
s3: adding 1.05 g of cherry powder into the mixed powder, and stirring and mixing;
s4: adding 0.5 g of dextrin powder into the mixed powder, stirring and mixing;
s5: adding 0.12 g of mogroside powder into the mixed powder, and stirring and mixing;
s6: adding 0.1 g of erythritol powder into the mixed powder, and stirring and mixing;
s7: 0.03 g of acesulfame potassium powder was added to the mixed powder, followed by mixing with stirring to obtain a solid beverage powder having a total mass of 5 g.
The formula table is shown in table 5:
table 5 ingredient formulation table
Example 5:
s1: weighing 2 g of sodium citrate powder and 0.8 g of citric acid powder, and stirring and mixing the sodium citrate powder and the citric acid powder, wherein the mass of the sodium citrate powder is 1.2 g, and the mass of the citric acid powder is 0.8 g;
s2: adding 2 g of inulin powder into the stirred and mixed powder, and stirring and mixing;
s3: adding 0.25 g of cherry powder into the mixed powder, and stirring and mixing;
s4: adding 0.64 g of dextrin powder into the mixed powder, stirring and mixing;
s5: adding 0.05 g of mogroside powder into the mixed powder, and stirring and mixing;
s6: adding 0.05 g of erythritol powder into the mixed powder, and stirring and mixing;
s7: 0.01 g of stevioside powder was added to the mixed powder, and stirred and mixed to obtain a solid beverage powder of 5 g in total mass.
The formula table is shown in table 6:
table 6 ingredient formula table
Example 6:
s1: weighing 2 g of sodium citrate powder and 1.4 g of citric acid powder, and stirring and mixing, wherein the mass of the sodium citrate powder is 0.6 g, and the mass of the citric acid powder is 1.4 g;
s2: adding 1.2 g of inulin powder into the stirred and mixed powder, and stirring and mixing;
s3: adding 1.05 g of cherry powder into the mixed powder, and stirring and mixing;
s4: adding 0.5 g of dextrin powder into the mixed powder, stirring and mixing;
s5: adding 0.12 g of mogroside powder into the mixed powder, and stirring and mixing;
s6: adding 0.1 g of erythritol powder into the mixed powder, and stirring and mixing;
s7: 0.03 g of stevioside powder was added to the mixed powder, and stirred and mixed to obtain a solid beverage powder having a total mass of 5 g.
The formula table is shown in table 7:
table 7 ingredient formulation table
The above description is only for the preferred embodiment of the present invention, but the scope of the present invention is not limited thereto, and any person skilled in the art should be considered to be within the technical scope of the present invention, and the technical solutions and the inventive concepts thereof according to the present invention should be equivalent or changed within the scope of the present invention.
Claims (8)
1. The formula of the compound solid beverage is characterized by comprising the following steps:
weighing 2 g of sodium citrate powder and citric acid powder in total, and stirring and mixing;
adding a certain amount of inulin powder into the stirred and mixed powder, and stirring and mixing;
adding a certain amount of fresh orange powder into the mixed powder, and stirring and mixing;
adding a certain amount of dextrin powder into the mixed powder, stirring and mixing;
adding a certain amount of mogroside powder into the mixed powder, and stirring and mixing;
adding a certain amount of erythritol powder into the mixed powder, and stirring and mixing;
adding a certain amount of acesulfame potassium powder into the mixed powder, and stirring and mixing to obtain solid beverage powder with the total mass of 5 g.
2. The formula of the compound solid beverage as claimed in claim 1, wherein 2 g of sodium citrate powder and citric acid powder are weighed and mixed, the mass of the sodium citrate powder is 0.6-1.2 g, and the mass of the citric acid powder is 0.8-1.4 g.
3. The formula of the composite solid beverage as claimed in claim 1, wherein a certain amount of inulin powder is added to the powder after stirring and mixing, and the inulin powder has a mass of 1.2-2 g.
4. The formula of the compound solid beverage as claimed in claim 1, wherein a certain amount of fresh orange powder is added to the mixed powder to be stirred and mixed, and the mass of the fresh orange powder is 0.25-1.05 g.
5. The formula of the composite solid beverage as claimed in claim 1, wherein a certain amount of dextrin powder is added to the mixed powder for stirring and mixing, and the mass of the dextrin powder is 0.3-0.8 g.
6. The formula of the composite solid beverage as claimed in claim 1, wherein a certain amount of mogroside powder is added to the mixed powder and stirred to mix, and the mass of the mogroside powder is 0.05-0.15 g.
7. The formula of the composite solid beverage according to claim 1, wherein a certain amount of erythritol powder is added to the mixed powder and stirred for mixing, and the mass of the erythritol powder is 0.05-0.1 g.
8. The formula of the composite solid beverage as claimed in claim 1, wherein a certain amount of acesulfame potassium powder is added to the mixed powder and stirred to obtain a solid beverage powder with a total mass of 5 g, and the mass of the acesulfame potassium powder is 0.01-0.03 g.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN202210439576.2A CN114794346A (en) | 2022-04-25 | 2022-04-25 | Formula of composite solid beverage |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN202210439576.2A CN114794346A (en) | 2022-04-25 | 2022-04-25 | Formula of composite solid beverage |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CN114794346A true CN114794346A (en) | 2022-07-29 |
Family
ID=82507375
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN202210439576.2A Pending CN114794346A (en) | 2022-04-25 | 2022-04-25 | Formula of composite solid beverage |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN114794346A (en) |
Citations (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| FR2883132A1 (en) * | 2005-03-15 | 2006-09-22 | Larena Sa | SUPPLETIVE FOOD COMPOSITION |
| CN103445171A (en) * | 2013-09-10 | 2013-12-18 | 杨康康 | Blood acid-base balancing agent |
| CN110799214A (en) * | 2017-04-18 | 2020-02-14 | 国立大学法人东北大学 | Blood purification with alkalizer |
-
2022
- 2022-04-25 CN CN202210439576.2A patent/CN114794346A/en active Pending
Patent Citations (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| FR2883132A1 (en) * | 2005-03-15 | 2006-09-22 | Larena Sa | SUPPLETIVE FOOD COMPOSITION |
| CN103445171A (en) * | 2013-09-10 | 2013-12-18 | 杨康康 | Blood acid-base balancing agent |
| CN110799214A (en) * | 2017-04-18 | 2020-02-14 | 国立大学法人东北大学 | Blood purification with alkalizer |
Non-Patent Citations (1)
| Title |
|---|
| 薛洪璐等: "《现代内科临床精要》", vol. 2, 吉林科学技术出版社, pages: 297 - 298 * |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN101810223B (en) | Functional milky tea powder and preparation method thereof | |
| CN106820117A (en) | A kind of weight losing meal-replacing powder | |
| KR101738912B1 (en) | Composition For Anti-obesity And Diet | |
| CN101049150A (en) | Edible nourishment health care potassium salt with extensive use | |
| CN102511861A (en) | Thickened red jujube pulp added with oligosaccharide | |
| CN103610183A (en) | Beverage for preventing excessive internal heat and preparation method thereof | |
| JP5749880B2 (en) | Body fat accumulation improving agent and metabolic syndrome improving agent comprising D-tagatose as an active ingredient | |
| CN101396115B (en) | Xylo-oligosaccharide stomach-invigorating intestine-moisturizing oral liquid and preparation method thereof | |
| KR20070113460A (en) | The health food composition for regulating weight | |
| CN102613461B (en) | Rapidly beautifying and weight losing nourishment and preparation method thereof | |
| JP6960988B2 (en) | Preventive or ameliorating agent for exacerbation of insulin resistance | |
| CN114794346A (en) | Formula of composite solid beverage | |
| EP1616570A1 (en) | Food for improving clinical conditions capable of lowering the concentration of low-molecular weight nitrogen-containing compounds in blood | |
| JP2002306130A (en) | Food and beverage for obesity prevention and amelioration | |
| JP2000189109A (en) | Liquid food | |
| JPH0995448A (en) | Increase in biotin concentration in blood and biotin-containing beverage or food product | |
| CN111165816A (en) | Weight-losing meal replacement powder for relaxing bowels and preparation method thereof | |
| CN110800893A (en) | Sucrose-free beverage with effects of reducing blood fat, reducing weight, promoting digestion, clearing heat, tonifying spleen, promoting diuresis and reducing blood sugar and preparation method thereof | |
| WO2008096171A2 (en) | Natural laxative composition comprising prunes, raisins, apricots, dates, figs, olive oil, senna and honey | |
| JP2002320440A (en) | Cookie low in sugar content | |
| JP3581697B2 (en) | Diet food | |
| US20050214362A1 (en) | Appetite suppressant | |
| CN101623015B (en) | Novel nutrient bakery food capable of replacing dinner | |
| JP4468105B2 (en) | Calorie adjusted food | |
| JP4435882B2 (en) | Alcohol absorption inhibiting composition |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PB01 | Publication | ||
| PB01 | Publication | ||
| SE01 | Entry into force of request for substantive examination | ||
| SE01 | Entry into force of request for substantive examination |